Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde
- 5-ASA
- Weight decreased: postmarketing
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Weight decreased: common, 0% - 15.9%
- A77 1726
- Weight decreased: 1.96% - 2%
- APAs
- CGP 19835A
- Diane-35
- Enfuvirtide
- Weight decreased: 6.2% - 11.1%
- FTY720
- Weight decreased: 4.71% - 5%
- Glat copolymer
- Weight decreased: infrequent
- Histrelin
- Implanon
- Weight decreased: postmarketing
- Insulin
- K779
- Weight decreased: 1% - 29%
- L-Dmp
- Weight decreased: infrequent
- LiOH
- Lisinopril
- N-carbamylglutamate
- Nafarelin
- Octreotide
- Photofrin
- Weight decreased: 0% - 9%
- Photofrin II
- Romidepsin
- Weight decreased: 0% - 14.9%
- SU5416
- Stalevo 50
- Supremon
- Triphasil
- Triptorelin
- Trisequens
- UDCA
- Zyprexa Relprevv
- acamprosate
- Weight decreased: infrequent
- acitretin
- adefovir dipivoxil
- afatinib
- Weight decreased: common, 0% - 17%
- agomelatine
- alprazolam
- Weight decreased: 2.3% - 23%
- amiodarone
- amisulpride
- Weight decreased: 1% - 2%
- amlodipine
- amlodipine besylate
- amphetamine
- amphotericin B
- amsacrine
- anagrelide
- anastrozole
- apremilast
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- atazanavir
- Weight decreased: uncommon
- atomoxetine
- Weight decreased: common, 2% - 3%
- auranofin
- axitinib
- Weight decreased: 1% - 25%
- baclofen
- Weight decreased: uncommon
- bendamustine
- Weight decreased: 0% - 7.19%
- betaxolol
- bexarotene
- bicalutamide
- bleomycin hydrochloride
- boceprevir
- Weight decreased: very common, 9%
- bortezomib
- bosentan
- bromcresol green
- buprenorphine
- bupropion
- buspirone
- Weight decreased: infrequent
- busulfan
- cabazitaxel
- Weight decreased: 0% - 1%
- cabergoline
- cabozantinib
- Weight decreased: 0% - 48%
- capecitabine
- captopril
- carbidopa
- carnitine
- Weight decreased: 3% - 8%
- carvedilol
- cefditoren
- cevimeline
- cidofovir
- citalopram
- Weight decreased: postmarketing, infrequent, uncommon, common, frequent, 1.5%
- clindamycin phosphate
- clofarabine
- clofazimine
- clomipramine
- clonazepam
- clozapine
- Weight decreased: postmarketing
- colestyramine
- copolymer 1
- cortisol
- crizotinib
- Weight decreased: 0% - 10%
- cyproterone acetate
- darunavir
- dasatinib
- Weight decreased: 0% - 14%
- degarelix
- deprenyl
- desogestrel
- desvenlafaxine
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane
- dichlorphenamide
- diclofenac
- docetaxel
- Weight decreased: 0% - 27%
- donepezil
- Weight decreased: frequent, 3% - 5%
- dorzolamide
- dothiepin
- doxazosin
- doxercalciferol
- doxorubicin
- Weight decreased: common, 0% - 4%
- duloxetine
- Weight decreased: postmarketing, frequent, 2%
- eletriptan
- emtricitabine
- entacapone
- Weight decreased: very rare
- eribulin
- Weight decreased: 1% - 21%
- erlotinib
- ertapenem
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam
- estradiol
- Weight decreased: postmarketing
- estradiol valerate
- ethionamide
- ethosuximide
- everolimus
- Weight decreased: common, very common, 0% - 28%
- exenatide
- febuxostat
- felbamate
- Weight decreased: 0% - 6.5%
- fenofibrate
- fentanyl
- Weight decreased: postmarketing, 3.23% - 10.3%
- fludarabine
- Weight decreased: 1% - 6%
- fluoxetine
- Weight decreased: common, 2% - 3%
- fluvoxamine
- Weight decreased: postmarketing, infrequent, frequent, 1% - 2%
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril
- Weight decreased: uncommon
- gabapentin
- Weight decreased: infrequent
- galantamine
- Weight decreased: 5% - 7%
- ganciclovir
- gefitinib
- Weight decreased: 1.94% - 5.66%
- gemfibrozil
- gentamicin
- haloperidol
- Weight decreased: very rare, postmarketing
- histamine
- hydralazine
- Weight decreased: uncommon
- hydromorphone
- Weight decreased: 0.671% - 2.99%
- hydroxybutyrate
- Weight decreased: postmarketing
- hydroxychloroquine
- ibandronate
- ibuprofen
- icodextrin
- iloperidone
- Weight decreased: frequent
- imatinib
- Weight decreased: infrequent, common, 0% - 17.3%
- imipramine
- Weight decreased: very rare
- indapamide
- insulin detemir
- irinotecan
- isomannide
- isosorbide-5-mononitrate
- itraconazole
- ixabepilone
- Weight decreased: 0% - 6%
- ketoprofen
- lamotrigine
- Weight decreased: infrequent, 2% - 5%
- lanreotide
- Weight decreased: 3.45% - 14.8%
- leflunomide
- Weight decreased: postmarketing, common, 0% - 4%
- lenalidomide
- Weight decreased: postmarketing, common, 0% - 19.5%
- letrozole
- Weight decreased: uncommon, 0.125% - 7%
- leuprorelin acetate
- Weight decreased: uncommon, 39.1% - 50.2%
- levetiracetam
- Weight decreased: postmarketing
- levodopa/carbidopa
- levonorgestrel
- lisdexamfetamine dimesylate
- Weight decreased: 3% - 9%
- lisuride
- lithium
- lithium carbonate
- lomitapide
- loxapine
- maprotiline
- medroxyprogesterone acetate
- meloxicam
- memantine
- Weight decreased: frequent
- methadone
- methsuximide
- methylphenidate
- Weight decreased: postmarketing, common, 5.52% - 9.18%
- methysergide
- miglustat
- Weight decreased: 0% - 67%
- milnacipran
- mirtazapine
- Weight decreased: infrequent
- mitoxantrone
- modafinil
- Weight decreased: postmarketing
- molindone
- morphine
- mycophenolate mofetil
- mycophenolic acid
- nabumetone
- Weight decreased: postmarketing, 0.4%
- nalmefene
- naltrexone
- naproxen
- nefazodone
- Weight decreased: infrequent
- nifedipine
- Weight decreased: postmarketing
- nilotinib
- nilutamide
- nisoldipine
- nortriptyline
- ofloxacin
- olanzapine
- omeprazole
- oxaliplatin
- oxcarbazepine
- oxycodone
- oxymorphone
- paclitaxel
- Weight decreased: uncommon
- paliperidone
- pantoprazole
- paricalcitol
- paroxetine
- Weight decreased: infrequent, common, frequent, 1%
- pazopanib
- Weight decreased: 0% - 48%
- pentosan polysulfate
- pergolide
- Weight decreased: frequent
- perhexiline
- phenytoin
- pimozide
- pioglitazone
- pirfenidone
- pixantrone
- pomalidomide
- Weight decreased: 8.04% - 14%
- ponatinib
- Weight decreased: 0% - 13%
- posaconazole
- Weight decreased: 0.718% - 13.8%
- pramipexole
- Weight decreased: postmarketing, uncommon, common, 2%
- pravastatin
- Weight decreased: 0.6% - 3.3%
- prednisolone phosphate
- prednisone
- pregabalin
- Weight decreased: infrequent
- progesterone
- Weight decreased: postmarketing
- propafenone
- prostacyclin
- quetiapine
- Weight decreased: infrequent
- rabeprazole
- raltegravir
- raltitrexed
- ranitidine
- ranolazine
- rapamycin
- rasagiline
- Weight decreased: common, 2% - 9%
- reboxetine
- regorafenib
- Weight decreased: 14% - 32%
- retinoic acid
- Weight decreased: postmarketing, 17%
- ribavirin
- Weight decreased: very common, 6% - 29%
- rifapentine
- rifaximin
- riluzole
- Weight decreased: 3.7% - 4.8%
- risperidone
- Weight decreased: infrequent, 1% - 4%
- ritonavir
- Weight decreased: 0% - 2.4%
- rivastigmine
- Weight decreased: common, frequent, 1% - 8%
- roflumilast
- Weight decreased: 3.4% - 7.46%
- ropinirole
- Weight decreased: infrequent, 2%
- rotigotine
- rufinamide
- Weight decreased: postmarketing
- ruxolitinib
- saquinavir
- sertraline
- Weight decreased: postmarketing, infrequent, common
- sitaxsentan
- sofosbuvir
- sorafenib
- Weight decreased: postmarketing, 0% - 30%
- stavudine
- stiripentol
- sumatriptan
- sunitinib
- tacrolimus
- Weight decreased: postmarketing, uncommon
- tamoxifen
- Weight decreased: 0.5% - 23%
- tapentadol
- temozolomide
- Weight decreased: common, 1% - 3%
- temsirolimus
- tenofovir
- Weight decreased: 2% - 4%
- tenofovir disoproxil fumarate
- Weight decreased: 2% - 4%
- terbinafine
- Weight decreased: postmarketing
- thalidomide
- Weight decreased: 0% - 22.5%
- thyroxine
- tiagabine
- Weight decreased: frequent
- timolol
- Weight decreased: postmarketing
- tipranavir
- Weight decreased: uncommon, 2.2%
- tizanidine
- Weight decreased: infrequent
- tobramycin
- tolcapone
- tolmetin
- topiramate
- Weight decreased: postmarketing, rare, 2.5% - 31%
- trabectedin
- tramadol
- trazodone
- Weight decreased: 3.2% - 5.7%
- triamcinolone acetonide
- trihexyphenidyl
- trimethadione
- trovafloxacin
- v 1784
- Weight decreased: postmarketing, uncommon
- valdecoxib
- valganciclovir
- Weight decreased: 3% - 9%
- valproate
- vandetanib
- vemurafenib
- Weight decreased: postmarketing
- venlafaxine
- Weight decreased: common, 2% - 4%
- vincristine
- vinflunine
- vinorelbine
- Weight decreased: 0% - 21%
- vismodegib
- Weight decreased: 7.2% - 48.6%
- vitamin D2
- vorinostat
- zalcitabine
- zaleplon
- ziconotide
- zidovudine
- Weight decreased: 4.26% - 6.38%
- ziprasidone
- zoledronic acid
- zolpidem
- zonisamide
- Weight decreased: 1% - 3%
- zopiclone
- Weight decreased: infrequent
- zuclopenthixol
|
Drugs with this indication
|